ClinicalTrials.Veeva

Menu

Prevention of Atrial Fibrillation After Coronary Artery Bypass Grafting in Patients With Obstructive Sleep Apnea (PAFOS)

R

Rodrigo Pinto Pedrosa

Status

Completed

Conditions

Atrial Fibrillation
Coronary Artery Bypass Grafting
Obstructive Sleep Apnea

Treatments

Device: CPAP

Study type

Interventional

Funder types

Other

Identifiers

NCT02737215
PAFOS01

Details and patient eligibility

About

Background. Atrial fibrillation is one of the most common complications in the postoperative period of coronary artery bypass grafting (CABG) surgery and usually associated with increased length of hospital stay and higher hospital costs. Among the main mechanisms involved, excessive sympathetic activation, oxidative stress and inflammation are fundamental elements in the pathophysiology of obstructive sleep apnea. Objectives. To evaluate the effects of continuous positive airway pressure (CPAP) in reduction of atrial fibrillation after CABG in patients with obstructive sleep apnea. Methodological procedures: A multicenter randomized controlled study to compare the incidence of atrial fibrillation between the intervention group and the control group, both monitored seven days with Holter.

Enrollment

144 patients

Sex

All

Ages

30 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • apnea-hypopnea index > 15 events/hour

Exclusion criteria

  • ejection fraction < 45%
  • chronic atrial fibrillation
  • periprocedural instability (haemodynamic, neurological)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

144 participants in 2 patient groups

CPAP group
Active Comparator group
Description:
patients will receive CPAP therapy for the first 7 days after extubation from CABG
Treatment:
Device: CPAP
Control Group
No Intervention group
Description:
Patients will receive usal care

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems